Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal liposarcoma.

D C Mayes1, R E Fechner, J Y Gillenwater

  • 1Department of Pathology, University of Virginia Health Sciences Center, Charlottesville 22908.

The American Journal of Surgical Pathology
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxygen Opacity Measurements at High-Energy-Density Conditions.

Physical review letters·2025
Same author

Sequential spectral line analysis for accurate density and temperature diagnosis of laboratory opacity measurements.

The Review of scientific instruments·2025
Same author

Development of improved higher-order correction for the NIF opacity spectrometer.

The Review of scientific instruments·2024
Same author

Design and characterization of the time-resolved opacity spectrometer (OpSpecTR) for the NIF iron opacity campaign.

The Review of scientific instruments·2024
Same author

A generalized approach to x-ray data modeling for high-energy-density plasma experiments.

The Review of scientific instruments·2023
Same author

Density measurements for the National Ignition Facility (NIF) opacity platform.

The Review of scientific instruments·2022
Same journal

NF2/Merlin Immunohistochemistry Helps Distinguish Collecting Duct Carcinoma From Upper Tract Urothelial Carcinoma.

The American journal of surgical pathology·2026
Same journal

Neuroendocrine Carcinoma of the Gallbladder: Clinicopathologic and Immunohistochemical Analysis of 31 Cases.

The American journal of surgical pathology·2026
Same journal

Papillary Renal Neoplasm With Reverse Polarity Is a Distinct Distal Nephron-Derived Tumor With Unique Methylation Profile.

The American journal of surgical pathology·2026
Same journal

Biallelic ARID1A Alterations: A Promising Novel Biomarker for Risk Stratification and Management in Pediatric Malignant Hepatocellular Tumors.

The American journal of surgical pathology·2026
Same journal

Absent Cyclin D1 Expression in Myeloid Sarcomas Distinguishes From Malignant Histiocytic Neoplasms: When Morphologic Ambiguity is Deceptive.

The American journal of surgical pathology·2026
Same journal

Clinicopathologic Study of 39 Mismatch Repair-deficient Sarcomas Demonstrates Recurrent Histologic Patterns and Supports Universal Screening of Pleomorphic Rhabdomyosarcoma, Uterine Leiomyosarcoma, and Undifferentiated and Unclassified Sarcomas.

The American journal of surgical pathology·2026
See all related articles

A rare kidney liposarcoma recurred in a 52-year-old man after 13 years. The second recurrence became inoperable, highlighting challenges in managing this kidney cancer.

Area of Science:

  • Oncology
  • Urologic Oncology
  • Surgical Pathology

Background:

  • Liposarcomas are malignant tumors arising from fat cells.
  • Primary renal liposarcomas are exceptionally rare, posing diagnostic and therapeutic challenges.

Observation:

  • A 52-year-old male presented with a primary kidney liposarcoma.
  • The tumor recurred 13 years after initial resection.
  • A second recurrence occurred, rendering the tumor inoperable.

Findings:

  • Recurrence of liposarcoma in the kidney is possible even after extended disease-free intervals.
  • The clinical course can be aggressive, leading to unresectable disease.

Implications:

  • This case underscores the importance of long-term surveillance for patients with rare renal tumors.

Related Experiment Videos

  • The inoperable nature of the second recurrence highlights the need for novel therapeutic strategies for advanced liposarcoma.
  • Further research into the molecular mechanisms driving liposarcoma recurrence is warranted.